| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Country's Decision or any other Communication
Record information and status
Record ID
Date of creation
2019-05-22 11:00 UTC (Kine.Rautio.overland@miljodir.no)
Date of publication
2019-05-22 11:00 UTC (Kine.Rautio.overland@miljodir.no)

General information
Country submitting the decision or communication
  • Norway
Competent National Authority(ies) responsible for the decision or communication
Norwegian Ministry of Climate and Environment
P.O. Box 8013 Dep.
Norway, 0030
Phone:+47 22 24 90 90
Fax:+47 22 24 27 56
Url:Norwegian Ministry of Climate and Environment
Title / Reference number of the decision or communication
Decision to prohibit import, feed and industrial use of genetically modified maize line DAS-1507
Date of the decision
Is the decision taken prior to entry into force of the Protocol?
  • Norway
Is this an amendment to a previous decision / communication?
Decision or communication details
Subject(s) of the decision
Uses of the LMO(s)
  • LMOs for direct use as feed
  • LMOs for processing
Has the decision been taken in the absence of a domestic regulatory framework and in accordance with Article 11.6?
Importer’s or Applicant’s contact details
Dow Agrosciences Europe Ltd
Dow Agrosciences Europe Ltd
European Development Centre, 3 Milton Park
Abingdon, Oxon
United Kingdom of Great Britain and Northern Ireland, OX14 4RN
Phone:0800 689 8899
Pioneer Overseas Corporation
Pioneer Hi-Bred International Inc.
Des Moines
United States of America
Phone:+1 (515) 535-3200
Result of the decision
  • Prohibition of the import/use of the LMO(s)
Norway has by royal decree of 2 June 2017, prohibited the placing on the Norwegian market of the GM maize line 1507 for uses authorised in accordance with the EU's GMO Directive (2001/18/EC) for feed and industrial processes. The prohibition applies to living organisms only. The prohibition does not include import for laboratory or field experiments, such cases will be assessed under the Gene Technology Act on a case-by-case basis.

The prohibition of insect-resistant and herbicide-tolerant maizeline 1507 is based on an assessment of the ethical problems that arise in connection with the intended use. The maize line has conferred resistance to the herbicide glufosinate ammonium, which has been classified as having both acute and chronic adverse effects on mammal health, including reproductive health and foetal development. This herbicide was withdrawn from the Norwegian market in 2008 due to adverse effects on health and the environment. Importing maize line 1507 that is produced using glufosinate ammonium in another country is perceived by sizeable user groups in Norway as ethically problematic and unsustainable. With regards to the moral views of the Norwegian people, factors such as solidarity with farmers in developing countries and establishment of sustainable agricultural production systems are considered important in issues in relation to GMOs.

Further information regarding the prohibition can be found in the Royal decree of 2 June 2017 (attached).
LMO identification
DAS-Ø15Ø7-1 - Herculex™ I maize
Resistance to diseases and pests - Insects - Lepidoptera (butterflies and moths) Resistance to herbicides - Glufosinate
Show detection method(s)
Risk assessment
Food/feed and environmental risk assessment of genetically modified insect and herbicide-tolerant maize 1507
DAS-Ø15Ø7-1 - Herculex™ I maize
Resistance to diseases and pests - Insects - Lepidoptera (butterflies and moths)
Resistance to herbicides - Glufosinate
Decision document
Additional Information
Additional Information
The genetically modified maize line 1507 was approved for feed and industrial uses under EU-directive 2001/18/EC by Commission decision 8 August 2005. No authorisation is required in Norway for the deliberate release of genetically modified organisms (GMOs) that have been authorised in another EEA state in accordance with the EU's GMO Directive (2001/18/EC). The use of such GMOs is also authorised in Norway unless a national decision to prohibit them is made under the Gene Technology Act. The Norwegian authorities may prohibit or restrict placing on the market if in their view it involves a risk to health or the environment, or if placing on the market is otherwise in conflict with the purpose of the Gene Technology Act, provided that their decision is otherwise in accordance with the EEA Agreement, see section 10, sixth paragraph, of the Gene Technology Act and the adaptations set out in Annex XX, item 25 d, to the EEA Agreement. According to the objects clause of the Gene Technology Act, the purpose of the Act is to ensure that the use of genetically modified organisms takes place in an ethically justifiable and socially acceptable manner, in accordance with the principle of sustainable development and without adverse effects on health and the environment. In legal terms, all production and use of genetically modified organisms apart from contained use in closed laboratory facilities is considered to be deliberate release.

The prohibition of placing on the market as feed and for industrial uses is found in the regulations FOR-2000-12-15-1268, on the prohibition of marketing in Norway of specific genetically modified products.
Other relevant website address or attached documents